Skip to main content
. 2020 Dec 10;12(12):3711. doi: 10.3390/cancers12123711

Figure 3.

Figure 3

Overall survival and disease-specific survival in patients with IBC stratified by estrogen receptor (ER) status and NDRG1 expression. Patients with ER-negative tumors had (a) worse overall survival and (b) worse disease-specific survival versus patients with ER-positive tumors. (c,d) Stratification of patients by ER and NDRG1 expression status in terms of overall survival and disease-specific survival. Log-rank tests were used to obtain p values. (e,f) Median overall survival and disease-specific survival times, in years, for patients stratified by ER status and NDRG1 expression.